Browsing by Author "Delgado Ochoa, Alex Santiago"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Riesgo a desarrollar síndrome de apnea/hipopnea del sueño (SAHS) en pacientes atendidos en el Centro de Especialidades Médicas (CEM), mediante la implementación del test Stop-Bang. Cuenca 2024
    (Universidad de Cuenca, 2025-07-04) Delgado Ochoa, Alex Santiago; García Orellana, Daniel Eduardo; Ojeda Orellana, Karina Paola
    Background: Sleep Apnea/Hypopnea Syndrome is a disease that has increased in recent years, which is characterized by interrupted sleep, frequent awakenings and moments of cessation of breathing (apneas). It is related to pathologies such as overweight and obesity, which generate a higher risk of developing complications such as cardiovascular diseases: arterial hypertension, heart failure, coronary artery disease, arrhythmias, stroke and pulmonary hypertension. The study of choice for the detection of this syndrome is Polysomnography, but due to its high cost and difficult access, methods have been developed to detect the risk of developing this pathology such as the "Stop-Bang" test with the aim of classifying patients and in those that the test results in a high risk to refer to a specialist in order to give an early and timely management. Objective: Determinig the level of risk of developing Sleep Apnea/Hypopnea Syndrome (SAHS) by applying the Stop-Bang Test. Method and Materials: Descriptive and cross-sectional study. The “Stop-Bang” test was used for data collection and was applied to 384 patients attended on an outpatient basis at the “Centro de Especialidades Médicas” (CEM) during the period February-May 2024. Results: A total of 384 anonymous questionnaires were completed, resulting in 240 patients with low risk of SAHS, representing 62.5% of the study population; 83 patients with moderate risk, representing 21.6% of the study population; and 61 patients with high risk of SAHS, representing 15.9% of the study population; concluding with a prevalence of moderate to high SAHS in 37.5% of the study population.